MEDIA
< Back
31 October 2018
Winter Capital invites applications for the Surpass Dreams scholarship programme

Winter Capital invites applications for the Surpass Dreams scholarship programme

31 October 2018

Winter Capital invites university students studying in financial, economic and mathematical specialties to take part in the “Surpass Dreams” partner scholarship programme.

The programme was founded by the partners of Troika Dialog investment company. It has an educational focus, with the aim of supporting talented students, helping them to realise their professional and creative potential.

The training is free and conducted by recognised experts and financial market gurus – business owners and leaders of well-known companies. The best graduates of the Surpass Dreams programme will receive the opportunity to have an internship in partner companies, including Winter Capital.

Application is available from the programme’s website until 5 November 2018 inclusive: https://www.troikastudents.org

6 September 2018
Petrovax Pharm produces Grippol® Quadrivalent and launches 3rd production line

Petrovax Pharm produces Grippol® Quadrivalent and launches 3rd production line

6 September 2018

Petrovax Pharm has launched production of Grippol® Quadrivalent, the first Russian 4-valent vaccine to prevent flu. Presently it is the most advanced full-cycle flu vaccine manufactured in Russia. The new vaccine is expected to further enhance the quality of the national healthcare system in the area of influenza prevention, and to provide a boost to Russia's pharmaceuticals exports.

Petrovax Pharm has also finished the construction of a RUB 1bn production line for drug substances and finished dosage forms. It will allow the company to increase the production of APIs by more than twofold, suppositories 4-fold, tablets 7-fold and create more than 70 new jobs. This project will spur the company’s growth in the Russian pharma market, expanding its export capacity and creating contract manufacturing expansion prospects, including import substitution opportunities.

Petrovax Pharm’s manufacturing complex has been operating under all applicable GMP and ISO guidelines for 10 years and is currently one of the most advanced high-tech biopharma facilities in Russia.

31 August 2018
Home Market completes rebranding process

Home Market completes rebranding process

31 August 2018

Home Market recently completed a significant rebranding of its operations. The project, which lasted slightly more than a year, was successfully completed today. More than 100 dollar stores formerly operating under the "ZaOdno" brand were rebranded to become part of the non-food discount retail chain "Home Market". Home Market’s concept offers its customers the possibility to save money when acquiring household items in easily accessible locations. A wide range of non-food goods meets the everyday needs of its customers across Russia.

Home Market operates in 18 Russian regions today, while the company management is actively preparing for a major regional expansion.

17 August 2018
UCG successfully completed significant certification process and received NEK 606 certificate

UCG successfully completed significant certification process and received NEK 606 certificate

17 August 2018

In September 2018, UCG successfully completed a significant certification process, receiving a NEK 606 certificate issued by the DNV GL classification society. The certificate confirms full compliance of UCG’s cables with the highest international standards for offshore oil & gas applications, which include resistance to drilling fluids, oils, ultraviolet and other aggressive environments.

While UCG’s presence in the offshore oil & gas industry was previously limited to projects in Russia and CIS, receipt of a NEK 606 certificate paves the way for the company to extend its product offering to the global market.

26 June 2018
Winter Capital and McKinsey announce the launch of the third annual startup competition “Pervaya Vysota”

Winter Capital and McKinsey announce the launch of the third annual startup competition “Pervaya Vysota”

26 June 2018

Winter Capital and McKinsey announce the launch of a startup competition “Pervaya Vysota”, which will be held this year for a 3rd time. The winner of the contest will receive $200,000 in equity funding from Winter Capital and a 6-month intensive mentorship program from Winter Capital and McKinsey professionals.

In the first two seasons of Pervaya Vysota more than 400 startups from various fields of the Russian economy have taken part in the competition. Young entrepreneurs have showcased their business ideas in a wide range of online and offline industries - from specialized retail to e-commerce, machine learning, service marketplaces and many others. Four winners of the competition – Particle, Eristica, Gavels and Heedbook – received funding of over $400,000 from Winter Capital.

Pervaya Vysota will accept applications from startups until August 12; the final round of 2018 competition will be held at the McKinsey Moscow office on September 28.

More on pervaya-vysota.ru

2 April 2018
KidZania US hires a new CEO

KidZania US hires a new CEO

2 April 2018

In April 2018, Greg Stevens was appointed as the CEO of KidZania US. Prior to joining the team he held the role of CEO of GameWorks Entertainment, where he worked from 2012. In addition, Greg held various earlier positions at JBC Entertainment, Blackstreet Capital and Jillian's Entertainment Holdings. He will oversee the development of the first US-based KidZania parks in Dallas and Chicago.

26 February 2018
UCG has launched production of rubber cables

UCG has launched production of rubber cables

26 February 2018

UCG has launched production of rubber cables at its facility in Podolsk, Moscow region. The new production area is equipped with state-of-the-art extrusion lines supplied by Troester, Germany. With the launch of rubber cable production UCG is able to offer a full range of specialty cables for naval and civil shipbuilding, offshore oil&gas and other demanding industrial applications.

14 September 2017
Petrovax has successfully finalized clinical trials of Grippol® Quadrivalent

Petrovax has successfully finalized clinical trials of Grippol® Quadrivalent

14 September 2017

Petrovax has successfully finalized clinical trials of Grippol® Quadrivalent – the first Russian influenza vaccine that protects against 4 strains of influenza virus.

Quadrivalent influenza vaccines have been recommended by the WHO since 2012. Currently, only five countries in the world manufacture quadrivalent vaccines, namely Australia, USA, Canada, Germany, and France. Russia will be the sixth country to independently manufacture such vaccine.

More on petrovax.com

1 September 2017
Winter Capital increases its shareholding in Auto1

Winter Capital increases its shareholding in Auto1

1 September 2017

Winter Capital continues to increase its ownership in Auto1, the leading European used-car marketplace currently operating in 30 countries.

During its latest round of financing Auto1 was valued at approximately $2.8 billion. Investors in this round included Baillie Gifford & Co, Princeville Global and Target Global. The company valuation has more than doubled since it was valued at approximately $1 billion in a funding round in 2015. Auto1 aims to achieve a 10% market share in mainland Europe in the medium to long term.

More on auto1.com

22 August 2017
ZaOdno launches new format of stores

ZaOdno launches new format of stores

22 August 2017

Russian dollar store chain, ZaOdno, launched a new discount format under the “Home Market” brand. 10 pilot stores were opened in the Moscow, Tula and Orel regions in August 2017.

The new concept aims to provide customers with a variety of inexpensive non-food merchandise in easily accessible locations. Each store is around 250-350 m2.

To improve shopping experience Home Market offers a large variety of product categories at low prices.

The new stores are different from traditional ZaOdno stores not only in their product range and pricing policy but also in their design and presentation.

More on homemrkt.ru

21 June 2017
Winter Capital and McKinsey launched a startup competition “Pervaya Vysota”

Winter Capital and McKinsey launched a startup competition “Pervaya Vysota”

21 June 2017

Winter Capital and McKinsey launched the startup competition “Pervaya Vysota” for the second time. This year one winner will receive $200,000 as an investment and mentorship from both Winter Capital and McKinsey professionals. The final round of the competition will take place at Red October on September 22.

In Pervaya Vysota 2016 the three winners were Particle (data searching and analysis platform), Eristica (social betting mobile application) and Gavels (online auctions for residential real estate). Each project received $75,000 as an investment and mentorship.

More on pervaya-vysota.ru

8 June 2017
DocPlanner received additional financing in Series D funding round

DocPlanner received additional financing in Series D funding round

8 June 2017

DocPlanner, one of the largest European SaaS and lead generation platforms for healthcare services, has closed a €15mn Series D funding round, which was led by Target Global, Enern Investments and One Peak Partners. The new funding round follows the merger with Doctoralia, a Spain-based company operating in more than 20 countries, and brings the total amount raised by DocPlanner to €46mn. The company plans to use the new capital to develop offices in Brazil and Mexico, reinforce its marketing and sales operations in core markets as well as improve its product offering to doctors.

More on docplanner.com

28 March 2017
Winter Capital announces investment into KidZania – children edutainment parks operator

Winter Capital announces investment into KidZania – children edutainment parks operator

28 March 2017

Winter Capital has invested into Innova Partners, an operator of KidZania parks which provide children aged 4-14 with an opportunity to engage in real life role play experience which blends learning with entertainment. The company launched a park in Moscow in January 2016 and plans to expand its operations into the US, France and Canada. The first US park is expected to be launched in Dallas in 2018. KidZania, launched in 1999, has 24 locations in 19 countries, with another seven locations currently under development.

21 February 2017
UCG initiates export sales with the first contract in India

UCG initiates export sales with the first contract in India

21 February 2017

UCG, one of the leading manufacturers of shipbuilding cable across Russia and CIS, signed its first contract with an Indian customer. The company will supply power cables for 7 ships which are being constructed by Larsen & Toubro, one of the largest shipbuilders in India. This contract marks the beginning of UCG’s international expansion as the company plans to bring its expertise and solutions to markets outside of Russia and CIS.

1 November 2016
Petrovax became the 1st Russian GMP compliant producer of veterinary products

Petrovax became the 1st Russian GMP compliant producer of veterinary products

1 November 2016

In October 2016 the Federal Service for Veterinary and Phytosanitary Surveillance (Rosselkhoznadzor) following the audit approved the issuance of a GMP certificate for Petrovax to manufacture the veterinary medicines AZOXIVET and Vetolaza. The Company has taken the lead as the 1st Russian manufacturer of veterinary drugs that complies with the GMP standards approved in Russia.

More on petrovax.com

29 October 2016
ZaOdno opened its 100th store

ZaOdno opened its 100th store

29 October 2016

ZaOdno, a leading Russian dollar store operator, has announced the opening of its 100th store, which took place on October 29. Located in Mytishchi, Moscow region, the store occupies 350 square meters of floor space in Krasny Kit, a popular local mall. The store offers a wide range of everyday consumer products, general merchandise and seasonal items. The store’s opening marks another major milestone for the company, which is aiming to become an alternative to traditional retail stores. ZaOdno has been able to significantly broaden its customer base by delivering value on day-to-day purchases, and now has more than 1.5 million monthly visitors. It is expected that the retailer will continue to demonstrate significant growth rates through active expansion into the regions and further diversification of its product range.

More on zaodno.ru

15 August 2016
Winter Capital and McKinsey have announced the winners of startup competition

Winter Capital and McKinsey have announced the winners of startup competition

15 August 2016

The final round of startup competition “Pervaya Vysota” took place on 12 August at Digital October. The panel of judges (Alexey Bashkirov and Mikhail Tsyferov from Winter Capital Advisors, Dmitry Garanin and Evgeny Yakushkin from McKinsey and Julia Solovieva from Google) have selected 3 winners: Particle (talent search platform), Eristica (social betting mobile application) and Gavels (online auctions for residential real estate). Three winners will receive $75,000 each in exchange for a 10% stake in the company and half-year mentorship from Winter Capital Advisors and McKinsey professionals.

More info on pervaya-vysota.ru

9 June 2016
Petrovax launches localization project with Boehringer Ingelheim

Petrovax launches localization project with Boehringer Ingelheim

9 June 2016

Petrovax and Boehringer Ingelheim, a global pharmaceutical company, have signed an agreement to localize the full-cycle production of the most advanced thrombolytic drugs in Russia. The medicines are used for urgent treatment of infarctions and cerebrovascular accidents. The agreement effected as part of Russia's 2020 Pharmaceutical Industry Development Strategy (Pharma 2020). It is another step towards making essential lifesaving medicines more affordable in Russia.

For Boehringer Ingelheim this is the first localization project of its kind: by the end of 2019 Petrovax plans to complete the transfer of technology, quality controls and launch full-cycle production of thrombolytics at its production facility in the Moscow Region.

More on petrovax.com

6 June 2016
DocPlanner announces a merger with one of its largest competitors Doctoralia

DocPlanner announces a merger with one of its largest competitors Doctoralia

6 June 2016

DocPlanner, one of the largest European SaaS and lead generation platforms for healthcare services, announces a merger with Doctoralia, a Spain-based company operating in more than 20 countries. As a result of the merger the combined entity will become one of the leading online platforms in healthcare globally with presence in Europe, South America and Asia. The merger succeeded spring 2016 Series C round led by Target Global in which DocPlanner raised c. $20mn.

More on docplanner.com

25 May 2016
Winter Capital and McKinsey have launched startup competition

Winter Capital and McKinsey have launched startup competition

25 May 2016

Winter Capital and McKinsey have jointly launched startup competition “Pervaya Vysota”. Three winners will receive $75,000 each in exchange for a 10% stake in the company and half-year mentorship from Winter Capital Advisors and McKinsey professionals. The final will take place in Digital October on 12 August.

More on pervaya-vysota.ru

 

7 April 2016
Kazakhstan to use Petrovax’s vaccine for anti-flu vaccination in 2016

Kazakhstan to use Petrovax’s vaccine for anti-flu vaccination in 2016

7 April 2016

Following a government tender, Petrovax was selected as the sole supplier of the full volume of anti-flu vaccine for the 2016-2017 epidemiological season population of Kazakhstan eligible for free vaccination (including children from six months of age, pregnant women, healthcare workers and people aged 60 and over). This is a well-deserved recognition of the efficacy, safety and high quality standards of Petrovax’s product. Importantly, this is the first time Kazakhstan has purchased a Russian vaccine. Previously, anti-flu vaccines has only been supplied by countries outside of the former Soviet Union

More on petrovax.com

28 March 2016
ZaOdno received additional financing from Winter Capital Partners

ZaOdno received additional financing from Winter Capital Partners

28 March 2016

ZaOdno, one of the fastest-growing dollar store chains in Russia, has received additional financing from Winter Capital Partners. The company will use the majority of the proceeds to further expand its footprint in Central Russia. The remaining funds will be spent on improving logistics, merchandising and CRM capabilities.

More on zaodno.ru

19 February 2016
Petrovax to localize flu vaccine production in Iran

Petrovax to localize flu vaccine production in Iran

19 February 2016

On 19 February 2016, Petrovax, Sobhan Recombinant Protein and Arvin LTD signed a trilateral strategic cooperation agreement to localize the production of Grippol® Plus flu vaccine in Iran. The signing took place at Petrovax's production facility and was attended by representatives of the Deputy Health Minister and Head of the Food and Drug Organization of the Islamic Republic of Iran. As part of the cooperation, Petrovax will transfer its full-cycle production technology for the Russian Grippol® Plus flu vaccine to Sobhan Recombinant Protein (Iran) and train the Iranian company’s staff to replicate all production stages. Currently, Petrovax is the only Russian pharmaceutical company working to localize manufacturing of its innovative medicines in Iran.

More on petrovax.com